The FDA announced on 2015-08-20 that Hospira Inc. voluntarily recalled Ketamine Hydrochloride Injection, USP (100 mg/mL) due to defective containers. The agency cited customer complaints of cracked and leaking glass vials for the Class II recall.
How to tell if you have it
- Brand: Hospira
- Product: Ketamine Hydrochloride Injection, USP (100 mg/mL)
- Packaging: 5 mL multi-dose glass fliptop vials, 10 vials per box
- NDC: 00409-2051-05
- Lot codes: 43406DD (Exp 7/1/2016), 44255DD (Exp 8/1/2016)
- Distribution: Nationwide
The hazard
The recall addresses defective containers, specifically cracked and leaking glass vials. The FDA noted that these defects were identified through customer complaints.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include Fresenius Kabi Ketamine HCl Injection Recall (2026-02-05), Hikma Ramipril Capsules 10mg Recall (2026-08-24), and Wells Pharma Ketamine Injectable Solution Recall (2026-04-01).